Top Markets
Coin of the day
Lumosa Therapeutics Co., Ltd. Lumosa Therapeutics Co., Ltd.

Lumosa Therapeutics Co., Ltd.

6535
Kedudukan dalam Saham #14760
Lumosa Therapeutics Co., Ltd. is a clinical-stage pharmaceutical company,... Lumosa Therapeutics Co., Ltd. is a clinical-stage pharmaceutical company, headquartered in Taiwan, focused on developing innovative therapies for neurological and oncological diseases. Its most advanced product, LT-1001, an injectable analgesic, has completed Phase III clinical trials for the management of severe post-operative pain. The company's pipeline also includes LT3001, currently in Phase II for treating acute ischemic stroke; LT5001, which has finished Phase Ib trials for uremic pruritus; and LT2003, an oncology drug candidate in its preclinical development stage. Founded in 2000, Lumosa Therapeutics maintains its operational base in Taipei.
Harga Saham
$2.35
Modal Pasaran
$394.12M
Perubahan (1 hari)
-1.07%
Perubahan (1 tahun)
-64.75%
Negara
TW
Perdagangan Lumosa Therapeutics Co., Ltd. (6535)

Kategori

Sejarah pecahan saham untuk Lumosa Therapeutics Co., Ltd. (6535)
Saham Lumosa Therapeutics Co., Ltd. (simbol: 6535) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Sep 01, 2026.
Satu saham 6535 yang dibeli sebelum Sep 01, 2026 kini bersamaan dengan 0 saham 6535.
Senarai pecahan saham
Tahun Pecahan Gandaan Gandaan Kumulatif
Tidak cukup data untuk tarikh yang disediakan.
Pecahan saham untuk syarikat pesaing atau serupa
Syarikat Bilangan pecahan saham Gandaan Kumulatif Negara
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH